Cargando…
Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis
Pulmonary fibrosis (PF) is a devastating lung disease with limited treatment options. During this pathological process, the profibrogenic macrophage subpopulation plays a crucial role, making the characterization of this subpopulation fundamentally important. The present study revealed a positive co...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641087/ https://www.ncbi.nlm.nih.gov/pubmed/37965241 http://dx.doi.org/10.1016/j.bioactmat.2023.09.019 |
_version_ | 1785146697367683072 |
---|---|
author | Zhang, Wei Wan, Zhuo Qu, Di Sun, Wenqi Zhang, Liang Liang, Yuan Pan, Lei Jiang, Hua Ye, Zichen Wei, Mengying Yuan, Lijun Yang, Guodong Jin, Faguang |
author_facet | Zhang, Wei Wan, Zhuo Qu, Di Sun, Wenqi Zhang, Liang Liang, Yuan Pan, Lei Jiang, Hua Ye, Zichen Wei, Mengying Yuan, Lijun Yang, Guodong Jin, Faguang |
author_sort | Zhang, Wei |
collection | PubMed |
description | Pulmonary fibrosis (PF) is a devastating lung disease with limited treatment options. During this pathological process, the profibrogenic macrophage subpopulation plays a crucial role, making the characterization of this subpopulation fundamentally important. The present study revealed a positive correlation between pulmonary macrophages with higher mitochondrial mass (Mø(mitohigh)) and fibrosis. Among the Mø(mitohigh) subpopulation of CD206(+) M2, characterized by higher expression of dynamin 1-like (Drp1), as determined by flow cytometry and RNA-seq analysis, a therapeutic intervention was developed using an exosome-based formula composed of pathfinder and therapeutics. A pathfinder exosome called “exosome(MMP19) (Exo(MMP19))”, was constructed to display matrix metalloproteinase-19 (MMP19) on the surface to locally break down the excessive extracellular matrix (ECM) in the fibrotic lung. A therapeutic exosome called “exosome (therapeutics) (Exo(Tx))”, was engineered to display D-mannose on the surface while encapsulating siDrp1 inside. Prior delivery of Exo(MMP19) degraded excessive ECM and thus paved the way for Exo(Tx) to be delivered into Mø(mitohigh), where Exo(Tx) inhibited mitochondrial fission and alleviated PF. This study has not only identified Mø(mitohigh) as profibrotic macrophages but it has also provided a potent strategy to reverse PF via a combination of formulated exosomes. |
format | Online Article Text |
id | pubmed-10641087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106410872023-11-14 Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis Zhang, Wei Wan, Zhuo Qu, Di Sun, Wenqi Zhang, Liang Liang, Yuan Pan, Lei Jiang, Hua Ye, Zichen Wei, Mengying Yuan, Lijun Yang, Guodong Jin, Faguang Bioact Mater Article Pulmonary fibrosis (PF) is a devastating lung disease with limited treatment options. During this pathological process, the profibrogenic macrophage subpopulation plays a crucial role, making the characterization of this subpopulation fundamentally important. The present study revealed a positive correlation between pulmonary macrophages with higher mitochondrial mass (Mø(mitohigh)) and fibrosis. Among the Mø(mitohigh) subpopulation of CD206(+) M2, characterized by higher expression of dynamin 1-like (Drp1), as determined by flow cytometry and RNA-seq analysis, a therapeutic intervention was developed using an exosome-based formula composed of pathfinder and therapeutics. A pathfinder exosome called “exosome(MMP19) (Exo(MMP19))”, was constructed to display matrix metalloproteinase-19 (MMP19) on the surface to locally break down the excessive extracellular matrix (ECM) in the fibrotic lung. A therapeutic exosome called “exosome (therapeutics) (Exo(Tx))”, was engineered to display D-mannose on the surface while encapsulating siDrp1 inside. Prior delivery of Exo(MMP19) degraded excessive ECM and thus paved the way for Exo(Tx) to be delivered into Mø(mitohigh), where Exo(Tx) inhibited mitochondrial fission and alleviated PF. This study has not only identified Mø(mitohigh) as profibrotic macrophages but it has also provided a potent strategy to reverse PF via a combination of formulated exosomes. KeAi Publishing 2023-10-27 /pmc/articles/PMC10641087/ /pubmed/37965241 http://dx.doi.org/10.1016/j.bioactmat.2023.09.019 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Zhang, Wei Wan, Zhuo Qu, Di Sun, Wenqi Zhang, Liang Liang, Yuan Pan, Lei Jiang, Hua Ye, Zichen Wei, Mengying Yuan, Lijun Yang, Guodong Jin, Faguang Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title | Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title_full | Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title_fullStr | Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title_full_unstemmed | Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title_short | Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
title_sort | profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641087/ https://www.ncbi.nlm.nih.gov/pubmed/37965241 http://dx.doi.org/10.1016/j.bioactmat.2023.09.019 |
work_keys_str_mv | AT zhangwei profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT wanzhuo profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT qudi profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT sunwenqi profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT zhangliang profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT liangyuan profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT panlei profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT jianghua profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT yezichen profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT weimengying profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT yuanlijun profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT yangguodong profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis AT jinfaguang profibrogenicmacrophagetargeteddeliveryofmitochondrialprotectorviaexosomeformulaforalleviatingpulmonaryfibrosis |